Dopamine receptor D4 (DRD4) polymorphisms with reduced functional potency intensify atrophy in syndrome-specific sites of frontotemporal dementia

by P.M. Butler, W. Chiong, D.C. Perry, Z.A. Miller, E.D. Gennatas, J.A. Brown, L. Pasquini, A. Karydas, D. Dokuru, G. Coppola, V.E. Sturm, A.L. Boxer, M.L. Gorno-Tempini, H.J. Rosen, J.H. Kramer, B.L. Miller, W.W. Seeley
Published 2019-01-01